Genetics and pharmacogenetics of the leukotriene pathway
- 1 September 2009
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 124 (3) , 422-427
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- 5-Lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist lociPharmacogenetics and Genomics, 2009
- Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor responsePharmacogenetics and Genomics, 2009
- Cysteinyl leukotriene receptor 1 gene variation and risk of asthmaEuropean Respiratory Journal, 2008
- A functional G300S variant of the cysteinyl leukotriene 1 receptor is associated with atopy in a Tristan da Cunha isolatePharmacogenetics and Genomics, 2007
- Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukastPharmacogenetics and Genomics, 2007
- ALOX5 promoter genotype, asthma severity and LTC4 production by eosinophilsAllergy, 2005
- Characterization of within-subject responses to fluticasone and montelukast in childhood asthmaJournal of Allergy and Clinical Immunology, 2005
- Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthmaJournal of Allergy and Clinical Immunology, 2004
- The global burden of asthma: executive summary of the GINA Dissemination Committee ReportAllergy, 2004
- Aspirin intolerance. III. Subtypes, familial occurrence, and cross-reactivity with tartrazineJournal of Allergy and Clinical Immunology, 1975